APA (7th ed.) Citation

Inker, L. A., Heerspink, H. J. L., Tighiouart, H., Levey, A. S., Coresh, J., Gansevoort, R. T., . . . Greene, T. (2019). GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials. Journal of the American Society of Nephrology, 30(9), 1735. https://doi.org/10.1681/ASN.2019010007

Chicago Style (17th ed.) Citation

Inker, Lesley A., et al. "GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials." Journal of the American Society of Nephrology 30, no. 9 (2019): 1735. https://doi.org/10.1681/ASN.2019010007.

MLA (9th ed.) Citation

Inker, Lesley A., et al. "GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials." Journal of the American Society of Nephrology, vol. 30, no. 9, 2019, p. 1735, https://doi.org/10.1681/ASN.2019010007.